Statins have been sold for nearly forty years. In that time the proof they save lives has got thinner, and the number of people told to take them has kept climbing.
This blog is fanatic about FunFood (i.e. FUNctional Food to make us happier and healthier).
Friday, 9 October 2026
Statins
Tuesday, 15 September 2026
Outcomes of cardiovascular screening in men aged 60–64 years: the DANCAVAS II trial
What happened to 'statins save lives'? In this 31,000 person RCT over 7 years, CVD screening put 44.33% of people on statins (compared to 30.25% in non screening) but prevented neither deaths nor CV events (HR 0.96). Funny how I don't see this trial EVER being discussed by cardiologists. One major difference with this trial compared to so many other statin trials is that it is not funded by a statin maker.
The paper:
Outcomes of cardiovascular screening in men aged 60–64 years: the DANCAVAS II trial
Invitation to a comprehensive CT-based screening for subclinical CVD did not decrease death over 7 years among men aged 60–64 years but did increase severe bleeding. Because the trial was powered for events over 10 years, further follow-up is needed.
Friday, 31 July 2026
Why statins aren't the answer to heart disease
= = =
My latest article @ RTE Brainstorm
Related reading:
1. Preventing Inflammation and Cardiovascular Diseases
How Food Polar Lipids Can Reduce Inflammation
2. Dairy Fats and Cardiovascular Disease: Do We Really Need to Be Concerned?
Monday, 7 April 2025
UK’s most prescribed drug may reduce dementia risk by 13 per cent
source: The Times.
Research found that taking statins may have a protective effect even for people whose cholesterol is already quite low.
High cholesterol has long been associated with poor heart health — but it may also increase your risk of getting dementia, a new study has suggested.
A team from the National Research Foundation of Korea and the Korean Neurological Association matched around 109,000 adults with high LDL cholesterol, above 130 mg/dL, with the same number of people with low LDL levels.
Significantly more individuals with high cholesterol were diagnosed with dementia or Alzheimer’s in the six months after testing than those with lower LDL levels.
The research, published in the Journal of Neurology, Neurosurgery & Psychiatry also found that taking statins may have a protective effect even for people whose cholesterol is already quite low.
Individuals with low levels of “bad” LDL cholesterol had a 26 per cent lower risk of being diagnosed with dementia, and those who took statins reduced that risk by 13 per cent compared with those who did not take them.
ven among those with cholesterol levels below 70 mg/dL, which GPs consider low, taking statins seemed to reduce the risk of a dementia diagnosis by an additional 13 per cent compared with those who did not take the medication. This effect disappeared when cholesterol levels dropped very low.
The LDL cholesterol causes a build-up of plaque in the blood vessels and may trigger inflammation. Over time, this can lead to blockages that disrupt blood flow, resulting in heart attacks and strokes.
Last summer, a major study showed that high cholesterol in midlife was an important risk factor for dementia. According to research commissioned by The Lancet, elevated LDL levels are responsible for about 7 per cent of all dementia cases.
Previous studies have shown that statins, which lower cholesterol levels and are already the most commonly prescribed drug in the UK, can reduce the risk of developing dementia by around 20 per cent.
Exactly how LDL cholesterol harms the brain remains unclear. “There is clearly more to the story of Alzheimer’s than we first thought said Francesco Tamagnini, a neurophysiologist at the University of Reading who was not part of the current research. “My lab has looked into the idea that damage to the blood-brain barrier can lead to accumulation of LDL cholesterol in the brain and potentially alter the electrical activity of neurons.”
Researchers in the past have pointed out that high levels of cholesterol are associated with greater brain amyloid, which is believed to be key in Alzheimer’s disease.
• NHS should offer ‘polypill’ to cut heart disease, experts urge
“However, dementia risk is complex and influenced by many factors. Without a detailed picture of what’s going on in the brain we do not know if there is a direct link between lower cholesterol and reduced dementia risk”, said Julia Dudley, head of research at Alzheimer’s Research UK. “In the meantime, keeping our hearts healthy remains one of the most effective ways we can protect our brain health.”
About six in ten people in the UK have high cholesterol and 9.5 million Brits were dispensed a statin in 2022. But there are other ways to lower cholesterol. Cutting down on fatty foods, which are rich in saturated fats, such as sausages can help.
Adding more vegetables and foods with high fibre to your diet is also beneficial. Scientists have shown that tomatoes, almonds, avocados and oats, in particular, may help lower LDL levels. Regular physical activity, such as aerobics, can further reduce “bad” cholesterol and protect your brain health.
Thursday, 6 March 2025
The lipid hypothesis: is it dead? Yes, it is!
My latest book where I am writing about statins, cholesterol and why the lipid hypothesis is wrong
- - - - - - - - - - - - - - - -
One more paper on the cholesterol paradox / lipid hypothesis
The Cholesterol Paradox in Long-Livers from a Sardinia Longevity Hot Spot (Blue Zone)
Why We Need to Re-Focus Away from Statins and Omega-3 Supplements
3.1 The demonization of cholesterol
Monday, 10 June 2024
Ο μύθος της χοληστερόλης
Photo:
= = = = = = = = = = = = = = = = = =
Ο μύθος των στατινών έχει αρχίσει να γκρεμίζεται…
= = = = = = =
Πριν από λίγες μέρες στις 28 Μάη, , δημοσιεύθηκε στην επιστημονική επιθεώρηση Heart Rhythm ένα πολύ ενδιαφέρον άρθρο με τίτλο
Lower cholesterol levels are associated with an increased risk of atrial fibrillation.
Το εν λόγω άρθρο μελετά την συσχέτιση της χοληστερόλης με το ρίσκο εκδήλωσης κολπικής μαρμαρυγής. Και τα αποτελέσματα είναι πολύ ενδιαφέροντα. Ανεξάρτητα από τους άλλους παράγοντες ρίσκου για καρδιαγγειακά νοσήματα, χαμηλά επίπεδα χοληστερόλης προκαλούν αύξηση στον κίνδυνο εκδήλωσης μαρμαρυγής! Είναι εντυπωσιακό πλέον ότι ο μύθος της χαμηλής χοληστερόλης ότι μειώνει (και καλά!) το ρίσκο για διάφορες ασθένειες, καταρρίπτεται κάθε μέρα που περνά.
Ο μύθος των στατινών έχει αρχίσει να γκρεμίζεται…
Thursday, 1 February 2024
This is why Ancel Keys was wrong!
You may remember the nous behind the Seven Countries Study (SCS). His name is Ancel Keys and he investigated if there was a link between coronary disease, diet and...cholesterol.
Some populations showed a linear relationship between levels of cholesterol and deaths caused by heart problems. However, some populations (Greece and Italy, mainly and also the former Yugoslavia) didn't show any such correlation! Instead of looking into the diets of these cohorts, the SSC people made a correlation between total cholesterol and cardiac related deaths...
Today, GPs and medical doctors measure all the above parameters (as per picture) but their thinking and points of action are shortsighted as they look only at the absolute levels of LDL, total cholesterol and triglycerides.
What about though the ratio of HDL/LDL which is actually the main cause of concern, as we have explained in this book?
The picture data are mine.
The ratio of HDL (1.3) / LDL (2.8) is slightly less that 1/2.
How have I managed this? the answer is very very simple: twice a week fish or marine foods and every other day exercise (swimming, mountain bike and sprints). And also, a small bottle of Yakult every morning.
Next Monday, I am going to compete in track and field Munster competition, in the category M50 - i.e., men aged 50-54.
Being 54, I have no chance this year. But, hey it's the participation that matters not the victory.
M50 60m sprint is my event on Monday and getting ready for this event made me getting up from my chair/sofa and go to the track and run with my spikes. Also, having such a purpose, it probably helped me to having such a good ratio of HDL/LDL.
So, if your GP suggests you going on statins if you have high LDL and total cholesterol levels, ask her/him to consider the ratio HDL/LDL. You will challenge her/his beliefs and it might take them out of their comfort zones...but it's worth mentioning this to them.
Saturday, 18 November 2023
Αλήθειες και ψέματα για τις στατίνες και τις καρδιακές νόσους – Του Γιάννη Ζαμπετάκη*
Η λάθος προσέγγιση του ιατρικού κατεστημένου που θεωρεί την χοληστερόλη ως πρωτογενές αίτιο των καρδιαγγειακών ασθενειών.
= = = = = = = = = = = = = = = = = = = = = = = =
από το cibum.gr
Στις 14 Νοέμβρη, η έγκυρη εφημερίδα The Irish Times, είχε ολοσέλιδο αφιέρωμα στις καρδιαγγειακές ασθένεις και την σημασία της πρόληψης έναντι αυτών. Το άρθρο στην online έκδοση της εφημερίδας μπορείτε να το βρείτε εδώ.
Ο τίτλος του είναι: «Cardiovascular disease: The case for doing more on illness prevention, rather than just treatment» με υπότιτλο «Rethinking how to keep people well promises a ‘win win’ for the State and the individual».
Διαβάζοντας το άρθρο, μας προέκυψαν κάποιες απορίες…
Στατίνες και Χοληστερόλη
Ο αρθρογράφος αναλώνεται στο τι μπορούμε (και πρέπει) να κάνουμε για να μην ασθενήσουμε από καρδιαγγειακές ασθένειες αλλά δεν μιλά καθόλου για την παγκόσμια πρακτική των οικογενειακών γιατρών και των καρδιολόγων να συνταγογραφούν στατίνες.
Σημειώνω εδώ ότι οι στατίνες είναι φάρμακα που σταματούν 100% την βιοσύνθεση χοληστερόλης στον ανθρώπινο οργανισμό. Ο οργανισμός του ανθρώπου που καταναλώνει στατίνες ουσιαστικάm του στερείται αυτή η πολύτιμη ένωση (χοληστερόλη) που παίρνει μέρος σε πολλές και σημαντικές βιοχημικές λειτουργίες.
Οι στατίνες όμως έχουν ισχυρές παρενέργειες. Προκαλούν μυϊκό πόνο, απώλεια μυϊκού βάρους και σε ποσοστό 50% προκαλούν διαβήτη τύπου 2. Παρ’όλες αυτές τις επικίνδυνες παρενέργειες, ο ετήσιος τζίρος των στατινών σε παγκόσμιο κλίμακα είναι 20 δις δολλάρια! Ναι! Καλά διαβάσατε…20 δις δολλάρια.
Η BigPharma βγάζει πολλά λεφτά από τις στατίνες…
Η χρόνια φλεγμονή και οι καρδιαγγειακές ασθένειες
Αντί λοιπόν, η αρθρογράφος Sheila Wayman να επικεντρωθεί στην πρωτογενή αιτία των καρδιαγγειακών παθήσεων που είναι η χρόνια φλεγμονή, μας κάνει ένα αναλυτικό ρεπορτάζ για τα τρόφιμα, την διατροφή και τον τρόπο διαβίωσης, χωρίς όμως να αναφέρει ούτε μια φορά τις λέξεις «χρόνια φλεγμονή» και «στατίνες».
Με την ερευνητική μου ομάδα εστιάζουμε στην χρόνια φλεγμονή που προκαλεί συσσωμάτωση των αιμοπεταλίων στο αίμα μας και την δημιουργία της λεγόμενης αθηρωματικής πλάκας, που είναι το πρώτο στάδιο των καρδιαγγειακών ασθενειών.
Έχουμε δημοσιεύσει το 2018 ένα άρθρο με τίτλο «Inflammation, not Cholesterol, Is a Cause of Chronic Disease» που μπορείτε να βρείτε εδώ.
Αυτό το άρθρο μας έχει 246 παραπομπές στο google scholar, αριθμός που δείχνει ότι δεν έχει περάσει απαρατήρητο.
Μάλιστα, μια άλλη ερευνητική ομάδα έχει δημοσιεύσει ένα editorial με τίτλο «Cholesterol versus Inflammation as Cause of Chronic Diseases», στο οποίο οι τρεις πρώτες προτάσεις των δυο συγγραφέων από την Αυστραλία είναι οι εξής:
Tsoupras and colleagues have postulated, in a recent review in Nutrients, that the key to reducing the incidence of cardiovascular disease is to control the activities of inflammatory mediators such as platelet-activating factor (PAF) by diet, exercise, and healthy lifestyle choices [1]. We agree with this sensible conclusion, which is based on the extensive scientific literature. The authors argue that their proposal is contrary to the lipid (or cholesterol) hypothesis.
Τι θα πρέπει να κάνουμε τελικά;
Αν θέλουμε να μιλήσουμε λοιπόν στα σοβαρά για τις καρδιαγγειακές ασθένειες θα πρέπει να αναφερθούμε στις στατίνες, στη χρόνια φλεγμονή και στο πόσο λάθος είναι η προσέγγιση του ιατρικού κατεστημένου να θεωρεί την χοληστερόλη ως πρωτογενές αίτιο των καρδιαγγειακών ασθενειών και να συνταγογραφεί «με τον κουβά» στατίνες που… προκαλούν διαβήτη τύπου 2! Με άλλα λόγια, το 50% των ασθενών που λαμβάνουν στατίνες κάθε μέρα και που θα ασθενήσουν με διαβήτη τύπου 2, θα συνεχίσουν να λαμβάνουν στατίνες εφ’όρου ζωής αλλά θα πρέπει επιπλέον να λαμβάνουν και επιπρόσθετη φαρμακευτική αγωγή για τον… διαβήτη τύπου 2.
Καλές και άγιες οι συμβουλές του στυλ «μαγειρέψτε υγιεινά», «περπατάτε πιο πολύ», «μειώστε την κατανάλωση επεξεργασμένων τροφίμων (processed foods)», αλλά αν δεν πιάσουμε τον ταύρο (καρδιααγγειακές ασθένειες) από τα κέρατα (χρόνια φλεγμονή), τότε είμαστε σαν εκείνο το παραμύθι που μια πριγκίπισσα στεκόταν μπροστά στον καθρέφτη της και τον ρωτούσε πόσο όμορφη είναι!
Επιμύθιο
Για τον γράφοντα, οι πιο σημαντικοί παράγοντες που προκαλούν οξεία και χρόνια φλεγμονή είναι οι εξής:
- Κακή διατροφή και κακός τρόπος ζωής
- Ατμοσφαιρική ρύπανση
- Έλλειψη σωματικής άσκησης
- Κακή ψυχολογία και
- Χημειοθεραπεία (ναι, η χημειοθεραπεία προκαλεί φλεγμονή).
Θα πρέπει λοιπόν οι ομάδες R+D της βιομηχανίας τροφίμων να μελετήσουν σε βάθος την χρόνια φλεγμονή και να σχεδιάσουν αντιφλεγμονωδή τρόφιμα που θα βοηθήσουν τους καταναλωτές στην μάχη μας έναντι της χρόνιας φλεγμονής και έτσι θα μείνουμε μακριά από τις στατίνες!
Ιδού πεδίο δόξης λαμπρόν!

*O Γιάννης Ζαμπετάκης είναι Αναπληρωτής Καθηγητής Χημείας Τροφίμων, στο Τμήμα των Βιολογικών Επιστημών του Πανεπιστημίου Λίμερικ (UL) στην Ιρλανδία και “παίζει” πάντα Αριστερό Εξτρέμ.
Email: funfood16@gmail.com
Twitter: @yanzabet
Tuesday, 14 November 2023
Would you like to talk SERIOUSLY about Cardiovascular Diseases?
If we want to talk SERIOUSLY about cardiovascular diseases (CVD), then, today's article in the Irish Times with the fancy title "Cardiovascular disease: The case for doing more on illness prevention, rather than just treatment" is quite short-sighted.
In a full page on the hard copy of the newspaper (I bought it today to keep it as it's my birthday today), we can read about lifestyle choices, about the role (or rather non-role) of corporations and what we can do in order to decrease the CVD risk.
BUT
Cholesterol and inflammation are NOT mentioned at all!
Statins are NOT mentioned either (Statins have become one of the most widely prescribed medications in the world, with global sales estimated to be over $20 billion annually!). Maybe, talking about BIGPHARMA is a tabou term for the Irish Times, maybe...
The real cause of CVD is inflammation and NOT cholesterol.
Hence, if we want to talk seriously about CVD, then we need to address all the factors that cause acute inflammation, e.g. smoking, air pollution (i.e. burning Polish coal in open fires, chemical additives in the food chain and ....chemotherapy).
(more on this, you can read in chapters 3,6,7,8 and 9 in this book)
Till then, we can wonder... : Quo Vadis Irish Times?
Sunday, 31 January 2021
Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortalityin the elderly: a systematic review
*This is the first systematic review of cohortstudies where low-density lipoprotein cholesterol(LDL-C) has been analysed as a risk factor forall-cause and/or cardiovascular mortality inelderly people.
▪Lack of an association or an inverse associationbetween LDL-C and mortality was present in allstudies.
▪We may not have included studies where an evaluation of LDL-C as a risk factor for mortality was performed but where it was not mentioned in the title or in the abstract.
▪We may have overlooked relevant studies because we have only searched PubMed.
▪Minor errors may be present because some of the authors may not have adjusted LDL-C by appropriate risk factors.
▪Some of the participants with high LDL-C may have started statin treatment during the observation period and, in this way, may have added a longer life to the group with high LDL-C and some of them may have started with a diet able to influence the risk of mortality.
▪We may have overlooked a small number of relevant studies because we only searched papers in English.
the full paper is here
Wednesday, 18 November 2020
omega 3 and statins
time to stop taking statins and omega 3 for CVD?
Omega-3 offers no heart health benefit in statin-treated patients, study finds
Sunday, 24 May 2020
Science and "Conflict of Interest"
this post is about Science and the short paragraph at the end of all scientific publications titled "Conflict of Interest".
Have you seen these paragraphs in papers like?
1. Optimal Nutritional Status for a Well-Functioning Immune System Is an Important Factor to Protect against Viral Infections
Conflicts of Interest
Supported by AstraZeneca.
when the authors themselves explicitly declare these conflicts of interest, could such declarations raise any doubts ?
Let's talk about the data, then.
To conclude: omega-3 and statins do not lower cardiovascular risk. The cholesterol hypothesis can not explain CVDs morbidity; inflammation is the killer, as explained few days ago...
COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation
Friday, 23 November 2018
on Statin Wars (part 2)
- People with high cholesterol tend to live longer
- People with heart disease are more likely to have low levels of cholesterol
- Cholesterol-lowering at a population level does not reduce the rate of heart disease
[source Statin Nation]
Thursday, 22 November 2018
on Statin Wars
Wednesday, 19 September 2018
LDL ‘cholesterol’ Does Not Cause Cardiovascular Disease - Another New Study.
- The cholesterol hypothesis is based on misleading statistics and ignoring contradictory observations.
- Only around 15% of clinical trials that found a negative result for cholesterol-lowering are cited in other reports.
- There is no association between total cholesterol levels and the degree of arterial damage - in general, and also with regard to statin clinical trials.
- In the Framingham Heart Study. “For each 1 mg/dl drop in TC [total cholesterol] per year, there was an eleven percent increase in coronary and total mortality”.
- The LDL level of patients who have had a heart attack is lower than normal.
- Elderly people with higher LDL live the longest.
- Cardiovascular mortality has not decreased as a result of widespread statin treatment. Here is a quote from the paper that refers to this point:
“In a Swedish study including 289 of the 290 municipalities, no association was found between statin use and the change in mortality from acute myocardial infarction (AMI). Also, the American National Health and Nutrition Examination Survey found that during the period 1999-2006 the number of AMI and strokes increased from 3.4 to 3.7%, and from 2.0 to 2.9%, respectively. During the same period mean LDL-C level decreased from 126.1 to 114.8 mg/dL, and the self-reported use of lipid-lowering drugs increased from 8 to 13.4%. Furthermore, statin utilisation in 12 European countries between 2000 and 2012 was not associated with reduced CHD mortality or its rate of change over the years.”
Friday, 14 September 2018
a strong paper against LDL cholesterol
LDL-C Does Not Cause Cardiovascular Disease: a comprehensive review of current literature
For half a century, a high level of total cholesterol (TC) or low-density-lipoprotein cholesterol (LDL-C) has been considered to be the major cause of atherosclerosis and cardiovascular disease (CVD), and statin treatment has been widely promoted for cardiovascular prevention. However, there is an increasing understanding that the mechanisms are more complicated, and that statin treatment, in particular when used as primary prevention, is of doubtful benefit.
Areas covered
The authors of three large reviews recently published by statin advocates have attempted to validate the current dogma. This paper delineates the serious errors in these three reviews as well as other obvious falsifications of the cholesterol hypothesis.
Expert commentary
Our search for falsifications of the cholesterol hypothesis confirms that it is unable to satisfy any of the Bradford Hill criteria for causality, and that the conclusions of the authors of the three reviews are based on misleading statistics, exclusion of unsuccessful trials and by ignoring numerous contradictory observations.
= = =
our views
1. Inflammation, not Cholesterol, Is a Cause of Chronic Disease
2. Unhealthy obsession with total cholesterol reduction is thwarting CVD prevention
Wednesday, 12 September 2018
Cholesterol, fat, and human metabolism: a microbiome-based paradigm shift
| In 2014 Time Magazine reversed its position on dietary fat and CAD |
At the age of 64, after a morning playing golf, president Dwight D Eisenhower had his first heart attack. As Pulitzer Prize winning author Gary Taubes describes in his book “Good Calories, Bad Calories” Eisenhower’s heart attack “constituted a learning experience on coronary artery disease (CAD).” After the event, his doctors, considered the top experts in the field, gave the public a “lucid and authoritative description of the disease itself”, followed by twice-daily press conferences held on the president’s condition. Soon, most of America, particularly middle-aged men, became intently aware of dogma promoted by these “experts”: the notion that CAD is caused by eating foods high in fat and cholesterol.
Like much of the rest of the nation, Eisenhower began to avidly lower his fat and cholesterol intake. Yet this plan of attack was counterintuitive for Eisenhower who, before his heart attack, had none of these supposed risk factors connected with CAD. His blood pressure was only seldom elevated, his weight throughout his life remained around 172 pounds (considered optimal for his height). His total cholesterol was below normal – his last measurement before the attack was 165 mg/dl, a level that heart disease specialists today consider safe. He had even quit smoking six years earlier in 1949.
[you can read the rest of this fascinating paper here: Cholesterol, fat, and human metabolism: a microbiome-based paradigm shift ]
Thursday, 6 September 2018
two important papers on statins as published in BMJ
1. Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study
Abstract
2. Primary prevention with statins for older adults
(...)
Decision time
new study in BMJ : statins do not provide any benefit for elderly people, unless they have type 2 diabetes
A new study published today in the British Medical Journal has found statins do not provide any benefit for elderly people, unless they have type 2 diabetes. In order to understand the significance of this study it is useful to first discuss some background and some key important concepts.
[The full story and paper are here]
Thursday, 23 August 2018
The Impact of Nutrition and Statins on Cardiovascular Diseases (1st Edition)
The Impact of Nutrition and Statins on Cardiovascular Diseases
1st Edition
Description
Written from a food science, food chemistry, and food biochemistry perspective, the book provides an insight on the origin of cardiovascular diseases, an analysis of statin therapy, the side effects of statin use, and presents dietary intervention as an alternative solution to preventing cardiovascular diseases. This knowledge is important for practitioners and patients alike, as once a patient begins statin therapy, there is a risk to stopping. In addition, the book presents how the use of improved nutrition and dietary guidelines could decrease the dose of statins used to manage cardiovascular disease. The book focuses on the efficacy of nutrition and statins to address inflammation, inhibit the onset of cardiovascular diseases and provides nutrition information and suggested dietary interventions for people with high cardiovascular risk.
Key Features
- Includes a bioscience approach, focuses on inflammation and revisits the lipid hypothesis, and challenges the view that statins are a panacea
- Presents the view that nutritional interventions have considerable value not only for reducing cardiovascular risk for CVDs patients but also acting as the best precaution for "apparently healthy" people
- Advocates that nutritional habits that are formed at a young age are the best way to tackle the global epidemic that is CVDs
Readership
Table of Contents
Table of Contents
- The Origin of Chronic Diseases with Respect to Cardiovascular Disease - Ronan Lordan, Alexandros Tsoupras, and Ioannis Zabetakis
- Inflammation - Ronan Lordan, Alexandros Tsoupras, and Ioannis Zabetakis
- Inflammation and Cardiovascular Diseases - Alexandros Tsoupras, Ronan Lordan, and Ioannis Zabetakis
- The Lipid Hypothesis and The Seven Countries Study - Ronan Lordan, Alexandros Tsoupras, and Ioannis Zabetakis
- The Role of Cholesterol in Atherosclerosis, CVD, and Dietary Patterns - Alexandros Tsoupras, Ronan Lordan, and Ioannis Zabetakis
- Statins: Rationale, Mode of Action, and Side-effects - Sherif Sultan, Ashwini D’Souza, Ioannis Zabetakis, Ronan Lordan, Alexandros Tsoupras, Edel P Kavanagh, and Niamh Hynes
- Cardiovascular Risk: Assumptions, Limitations, and Research - Alexandros Tsoupras, Ronan Lordan, and Ioannis Zabetakis
- Diet and Cardiovascular Disease: The Mediterranean Diet - Audrey Tierney, Ronan Lordan, Alexandros Tsoupas, and Ioannis Zabetakis
- Nutrition Versus Statins in Primary Prevention: Where do we Stand Now? - Ioannis Zabetakis, Ronan Lordan, and Alexandros Tsoupras
Details
- No. of pages:
- 320
- Language:
- English
- Copyright:
- © Academic Press 2019
- Published:
- 1st January 2019
- Imprint:
- Academic Press
- Paperback ISBN:
- 9780128137925









